IBDEI1EG ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22637,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22637,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Face,Other
 ;;^UTILITY(U,$J,358.3,22637,1,4,0)
 ;;=4^C4A.39
 ;;^UTILITY(U,$J,358.3,22637,2)
 ;;=^5001146
 ;;^UTILITY(U,$J,358.3,22638,0)
 ;;=C4A.59^^76^974^84
 ;;^UTILITY(U,$J,358.3,22638,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22638,1,3,0)
 ;;=3^Merkle Cell CA,Parts of Trunk,Other
 ;;^UTILITY(U,$J,358.3,22638,1,4,0)
 ;;=4^C4A.59
 ;;^UTILITY(U,$J,358.3,22638,2)
 ;;=^5001150
 ;;^UTILITY(U,$J,358.3,22639,0)
 ;;=C4A.8^^76^974^82
 ;;^UTILITY(U,$J,358.3,22639,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22639,1,3,0)
 ;;=3^Merkle Cell CA,Overlapping Sites
 ;;^UTILITY(U,$J,358.3,22639,1,4,0)
 ;;=4^C4A.8
 ;;^UTILITY(U,$J,358.3,22639,2)
 ;;=^5001157
 ;;^UTILITY(U,$J,358.3,22640,0)
 ;;=C4A.9^^76^974^88
 ;;^UTILITY(U,$J,358.3,22640,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22640,1,3,0)
 ;;=3^Merkle Cell CA,Unspec
 ;;^UTILITY(U,$J,358.3,22640,1,4,0)
 ;;=4^C4A.9
 ;;^UTILITY(U,$J,358.3,22640,2)
 ;;=^5001158
 ;;^UTILITY(U,$J,358.3,22641,0)
 ;;=C84.09^^76^974^93
 ;;^UTILITY(U,$J,358.3,22641,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22641,1,3,0)
 ;;=3^Mycosis Fungoides,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,22641,1,4,0)
 ;;=4^C84.09
 ;;^UTILITY(U,$J,358.3,22641,2)
 ;;=^5001630
 ;;^UTILITY(U,$J,358.3,22642,0)
 ;;=C84.03^^76^974^96
 ;;^UTILITY(U,$J,358.3,22642,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22642,1,3,0)
 ;;=3^Mycosis Fungoides,Intra-Abdominal Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22642,1,4,0)
 ;;=4^C84.03
 ;;^UTILITY(U,$J,358.3,22642,2)
 ;;=^5001624
 ;;^UTILITY(U,$J,358.3,22643,0)
 ;;=C84.06^^76^974^97
 ;;^UTILITY(U,$J,358.3,22643,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22643,1,3,0)
 ;;=3^Mycosis Fungoides,Intrapelvic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22643,1,4,0)
 ;;=4^C84.06
 ;;^UTILITY(U,$J,358.3,22643,2)
 ;;=^5001627
 ;;^UTILITY(U,$J,358.3,22644,0)
 ;;=C84.02^^76^974^98
 ;;^UTILITY(U,$J,358.3,22644,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22644,1,3,0)
 ;;=3^Mycosis Fungoides,Intrathoracic Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22644,1,4,0)
 ;;=4^C84.02
 ;;^UTILITY(U,$J,358.3,22644,2)
 ;;=^5001623
 ;;^UTILITY(U,$J,358.3,22645,0)
 ;;=C84.04^^76^974^92
 ;;^UTILITY(U,$J,358.3,22645,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22645,1,3,0)
 ;;=3^Mycosis Fungoides,Axilla/Upper Limb Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22645,1,4,0)
 ;;=4^C84.04
 ;;^UTILITY(U,$J,358.3,22645,2)
 ;;=^5001625
 ;;^UTILITY(U,$J,358.3,22646,0)
 ;;=C84.01^^76^974^94
 ;;^UTILITY(U,$J,358.3,22646,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22646,1,3,0)
 ;;=3^Mycosis Fungoides,Head/Face/Neck Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22646,1,4,0)
 ;;=4^C84.01
 ;;^UTILITY(U,$J,358.3,22646,2)
 ;;=^5001622
 ;;^UTILITY(U,$J,358.3,22647,0)
 ;;=C84.05^^76^974^95
 ;;^UTILITY(U,$J,358.3,22647,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22647,1,3,0)
 ;;=3^Mycosis Fungoides,Inguinal Region/LE Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22647,1,4,0)
 ;;=4^C84.05
 ;;^UTILITY(U,$J,358.3,22647,2)
 ;;=^5001626
 ;;^UTILITY(U,$J,358.3,22648,0)
 ;;=C84.08^^76^974^99
 ;;^UTILITY(U,$J,358.3,22648,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22648,1,3,0)
 ;;=3^Mycosis Fungoides,Multiple Site Lymph Nodes
 ;;^UTILITY(U,$J,358.3,22648,1,4,0)
 ;;=4^C84.08
 ;;^UTILITY(U,$J,358.3,22648,2)
 ;;=^5001629
 ;;^UTILITY(U,$J,358.3,22649,0)
 ;;=C84.07^^76^974^100
